EICHOR
● Recruiting
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Condition: Lymphoma · Sponsor: Hoffmann-La Roche
About this study
The purpose of this study is to evaluate the efficacy of glofitamab monotherapy compared with an investigator's choice of either rituximab plus bendamustine (BR), or lenalidomide with rituximab (R-Len) in patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL).
This description comes directly from the study's public registry record.
Talk to the study team
Reference Study ID Number: GO43878 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
Locations (82)
| Alta Bates Summit Medical Center | Berkeley, California, United States | Withdrawn |
| City of Hope Cancer Center | Duarte, California, United States | Recruiting |
| Valkyrie Clinical Trials | Los Angeles, California, United States | Recruiting |
| University of California Los Angeles (UCLA) - Cancer Care - Santa Monica | Santa Monica, California, United States | Recruiting |
| Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Georgetown University | Washington D.C., District of Columbia, United States | Recruiting |
| University of Miami | Coral Gables, Florida, United States | Recruiting |
| Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Withdrawn |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| University of Iowa Health Care | Waukee, Iowa, United States | Recruiting |
| University of Michigan Health System | Ann Arbor, Michigan, United States | Recruiting |
+ 70 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06084936